Results 251 to 260 of about 2,709,664 (338)

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

, 2003
Stuart M. Sprague, Francisco Llach, Michael Amdahl, Carol Taccetta, Daniel Batlle   +4 more
openalex   +1 more source

Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel. [PDF]

PLoS One
Henner DE, Drambarean B, Gerbeling TM, Kendrick JB, Kendrick WT, Koester-Wiedemann L, Nickolas TL, Rastogi A, Rauf AA, Dyson B, Singer MC, Desai P, Fox KM, Cheng S, Goodman W.   +14 more
europepmc   +1 more source

Non-Oxidised Parathyroid Hormone and a Panel of Markers of Calcium-Phosphate Metabolism for Analysis of Secondary Hyperparathyroidism in Selected Patient Groups-A Quality Assurance Project. [PDF]

Int J Mol Sci
Huber-Schoenauer U, Cadamuro J, Kipman U, Stoellinger E, Lichtenauer M, Paar V, Kedenko L, Guggenbichler K, Paulweber B, Pirich C, Salmhofer H.   +10 more
europepmc   +1 more source

Preoperative total parathyroid volume is an independent marker to predict recurrence for secondary hyperparathyroidism. [PDF]

Ann Med
Wang Z, Zhang F, Zhu C, Wu C, Meng X, Wang X.   +5 more
europepmc   +1 more source

Surgical treatment of patients with secondary hyperparathyroidism in chronic renal failure

, 2003
В. Н. Сморщок, Н С Кузнецов, А. М. Артемова, Liudmila Rozhinskaya, D. G. Beltsevich   +4 more
openalex   +1 more source

Magnetic resonance manifestation of diffuse osteopenia in a cat with presumed nutritional secondary hyperparathyroidism, hypocobalaminaemia and thiamine deficiency. [PDF]

J Small Anim Pract
Skarbek A, Danciu CG, Fenn J, Klever J.
europepmc   +1 more source

Chronotherapy with Cinacalcet has a striking effect on inhibition of parathyroid gland proliferation in rats with secondary hyperparathyroidism. [PDF]

PLoS One
Egstrand S, Mace ML, Morevati M, Engelholm LH, Thomsen JS, Brüel A, Olgaard K, Lewin E.   +7 more
europepmc   +1 more source

Parathyroid gland volume and treatment resistance in patients with secondary hyperparathyroidism: a 4-year retrospective cohort study. [PDF]

Clin Kidney J
Kato K, Nakashima A, Morishita M, Ohkido I, Yokoo T.   +4 more
europepmc   +1 more source

Maxacalcitol, a medicine for secondary hyperparathyroidism (2°HPT)

, 2003
Ikuo Imazeki
openalex   +2 more sources